subchapter_subject: "ANIMAL DRUGS, FEEDS, AND RELATED PRODUCTS"
part_code: "529"
part_subject: "CERTAIN OTHER DOSAGE FORM NEW ANIMAL DRUGS"
subpart_code: "B"
subpart_subject: "Specific Administrative Rulings and Decisions"
section_number: "529.778"
section_subject: "Doxycycline."
cfr_reference: "21 CFR 529.778"
title_name: "Title 21"
title_subject: "Food and Drugs"
parts_covered: "Parts 500 to 599"
revised_date: "Revised as of April 1, 2019"
publication_date: "As of April 1, 2019"
contains_description: "Containing a codification of documents of general applicability and future effect"
publication_info: "Published by the Office of the Federal Register National Archives and Records Administration as a Special Edition of the Federal Register"
---
(a)Specifications. Doxycycline hyclate solution contains 8.5 percent doxycycline activity. A syringe of N-methyl-2-pyrrolidone and poly (DL-lactide) mixed with a syringe of doxycycline produces 0.5 milliliter of solution.
(b)Sponsor. See 054771 in § 510.600(c) of this chapter.
(c)Conditions of use in dogs—(1) Amount. Apply subgingivally to periodontal pocket(s) of affected teeth.
(2)Indications for use. For treatment and control of periodontal disease.
(3)Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian.